Clinical Trial Update: Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating entecavir in patients with decompensated HBV-related cirrhosis; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Cirrhosis
• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Hepatitis B Virus, Decompensated Cirrhosis | Phase 4 | Status: UNKNOWN